心脏代谢疾病的综合护理模式。
Comprehensive Care Models for Cardiometabolic Disease.
机构信息
Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Department of Radiology and Neuroradiology, Charité, Berlin, Germany.
出版信息
Curr Cardiol Rep. 2021 Feb 24;23(3):22. doi: 10.1007/s11886-021-01450-1.
Abstract
PURPOSE OF REVIEW
The high burden of cardiovascular disease and the simultaneous obesity pandemic is placing an extraordinary strain on the health care system. In the current siloed care model, patients with cardiometabolic disease receive only fractionated care from multiple specialists, leading to insufficient treatment, higher costs, and worse outcomes.
RECENT FINDINGS
The imminent need for a new care model calls for the creation of a distinct cardiometabolic specialty in conjunction with a cardiometabolic outpatient clinic dedicated to the comprehensive cardiometabolic care. The cardiometabolic clinic would consist of a diverse range of professionals relevant to comprehensive treatment. The outpatient clinic we envision here would facilitate an interdisciplinary collaboration between specialists and deliver prevention-focused treatment to patients at risk/established cardiometabolic disease.
摘要
目的综述
心血管疾病负担沉重，肥胖症同时流行，这给医疗系统带来了巨大压力。在当前的割裂式医疗模式下，患有心脏代谢疾病的患者仅从多个专科医生那里获得部分治疗，导致治疗不足、成本增加和预后更差。
最近的发现
迫切需要一种新的医疗模式，因此需要创建一个专门的心脏代谢专科，并设立一个心脏代谢专科门诊，以提供全面的心脏代谢护理。心脏代谢诊所将由各种与综合治疗相关的专业人员组成。我们在这里设想的门诊部将促进专家之间的跨学科合作，并为有风险/已确诊心脏代谢疾病的患者提供以预防为重点的治疗。
相似文献
1
Comprehensive Care Models for Cardiometabolic Disease.
Curr Cardiol Rep. 2021 Feb 24;23(3):22. doi: 10.1007/s11886-021-01450-1.
2
Cardiometabolic medicine - the US perspective on a new subspecialty.
Cardiovasc Endocrinol Metab. 2020 Jul 16;9(3):70-80. doi: 10.1097/XCE.0000000000000224. eCollection 2020 Sep.
3
Prevalence of frailty, cognitive impairment, and sarcopenia in outpatients with cardiometabolic disease in a frailty clinic.
BMC Geriatr. 2018 Nov 6;18(1):264. doi: 10.1186/s12877-018-0955-4.
4
Implementation of Cardiometabolic Centers and Training Programs.
Curr Diab Rep. 2022 May;22(5):203-212. doi: 10.1007/s11892-022-01459-y. Epub 2022 Mar 22.
5
Bridging the Gap for Patients with Diabetes and Cardiovascular Disease Through Cardiometabolic Collaboration.
Curr Diab Rep. 2019 Dec 4;19(12):157. doi: 10.1007/s11892-019-1260-0.
6
Risk Stratification and Treatment of Obesity for Primary and Secondary Prevention of Cardiovascular Disease.
Curr Atheroscler Rep. 2024 Jan;26(1):11-23. doi: 10.1007/s11883-023-01182-3. Epub 2023 Dec 30.
7
Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary).
Can J Cardiol. 2011 Mar-Apr;27(2):124-31. doi: 10.1016/j.cjca.2011.01.016.
8
Considerations and Guidance for the Structure, Organisation, and Operation of Cardiometabolic Prevention Units: A Consensus Statement of the Inter-American Society of Cardiology.
Glob Heart. 2021 Apr 27;16(1):27. doi: 10.5334/gh.960.
9
Quality of clinical management of cardiometabolic risk factors in patients with severe mental illness in a specialist mental health care setting.
Nord J Psychiatry. 2022 Nov;76(8):602-609. doi: 10.1080/08039488.2022.2039288. Epub 2022 Feb 24.
10
Cardiometabolic Medicine: Development of a New Subspecialty.
J Clin Endocrinol Metab. 2020 Jul 1;105(7). doi: 10.1210/clinem/dgaa261.
引用本文的文献
1
Analysis on the related factors of the influence of high-quality nursing service in cardiology department on patients' psychological mood and rehabilitation index.
Medicine (Baltimore). 2025 Aug 8;104(32):e43706. doi: 10.1097/MD.0000000000043706.
2
The Health Equity Action Network Research Coordinating Center Facilitates Meaningful Community Engagement to Promote Health Equity.
Am J Public Health. 2025 Jul;115(S2):S98-S103. doi: 10.2105/AJPH.2025.308177.
3
Clinical nursing effect of comprehensive nursing in department of respiratory medicine.
Front Med (Lausanne). 2025 Jun 4;12:1601061. doi: 10.3389/fmed.2025.1601061. eCollection 2025.
4
Association between estimated glucose disposal rate and incident cardiovascular disease in a population with Cardiovascular-Kidney-Metabolic syndrome stages 0-3: insights from CHARLS.
Front Cardiovasc Med. 2025 Feb 24;12:1537774. doi: 10.3389/fcvm.2025.1537774. eCollection 2025.
5
Mortality and Years of Life Lost From Cardiometabolic Diseases in Mexico: National and State-Level Trends, 1998-2022.
Public Health Rep. 2025 Jan 27:333549241308166. doi: 10.1177/00333549241308166.
6
Role and impact of a specialized cardiometabolic clinic in managing high-risk patients with type 2 diabetes and atherosclerotic cardiovascular disease.
Am J Prev Cardiol. 2024 Jul 1;19:100706. doi: 10.1016/j.ajpc.2024.100706. eCollection 2024 Sep.
7
ProtecT-2-D trial protocol: cardiovascular protection in patients with type 2 diabetes and established heart and/or vascular disease at a cardio-metabolic clinic-a randomized controlled trial.
Cardiovasc Diabetol. 2024 Jul 8;23(1):241. doi: 10.1186/s12933-024-02340-w.
8
Interplay between Vitamin D and Sphingolipids in Cardiometabolic Diseases.
Int J Mol Sci. 2023 Dec 4;24(23):17123. doi: 10.3390/ijms242317123.
9
Effect of comprehensive nursing on patients with chalazion undergoing intense pulsed light and its influence on postoperative recurrence.
Am J Transl Res. 2023 Sep 15;15(9):5691-5698. eCollection 2023.
10
Clusters of medical specialties around patients with multimorbidity - employing fuzzy c-means clustering to explore multidisciplinary collaboration.
BMC Health Serv Res. 2023 Sep 9;23(1):975. doi: 10.1186/s12913-023-09961-z.
本文引用的文献
1
Cardiometabolic Medicine: Development of a New Subspecialty.
J Clin Endocrinol Metab. 2020 Jul 1;105(7). doi: 10.1210/clinem/dgaa261.
2
Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery Disease-A Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE V.
Diabetes Care. 2020 Apr;43(4):726-733. doi: 10.2337/dc19-2165. Epub 2020 Feb 20.
3
Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity.
N Engl J Med. 2019 Dec 19;381(25):2440-2450. doi: 10.1056/NEJMsa1909301.
4
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
N Engl J Med. 2019 Nov 21;381(21):1995-2008. doi: 10.1056/NEJMoa1911303. Epub 2019 Sep 19.
5
The Role of the Clinical Pharmacist in a Preventive Cardiology Practice.
Ann Pharmacother. 2019 Dec;53(12):1214-1219. doi: 10.1177/1060028019864669. Epub 2019 Jul 25.
6
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9.
7
Use of Guideline-Recommended Risk Reduction Strategies Among Patients With Diabetes and Atherosclerotic Cardiovascular Disease.
Circulation. 2019 Aug 13;140(7):618-620. doi: 10.1161/CIRCULATIONAHA.119.041730. Epub 2019 Jun 7.
8
Medicare Annual Wellness Visit association with healthcare quality and costs.
Am J Manag Care. 2019 Mar 1;25(3):e76-e82.
9
Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.
Circulation. 2019 Mar 5;139(10):e56-e528. doi: 10.1161/CIR.0000000000000659.
10
Call to Action: Urgent Challenges in Cardiovascular Disease: A Presidential Advisory From the American Heart Association.
Circulation. 2019 Feb 26;139(9):e44-e54. doi: 10.1161/CIR.0000000000000652.
Zotero 插件